Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
VANCOUVER, Feb. 22, 2013 /CNW Telbec/ - Akela Pharma, Inc. (the "Corporation") has announced that its wholly owned subsidiary, Formulation...
VANCOUVER, Nov. 30, 2012 /CNW Telbec/ - Akela Pharma, Inc. (TSX:AKL) advises that it has applied for the voluntary delisting of its securities from...
AUSTIN, TX, Sept. 21, 2012 /CNW Telbec/ - Akela Pharma, Inc. (TSX: AKL) today announced that Mr. Beng Lai is stepping down as a member of the Board...
AUSTIN, TX, Aug. 14, 2012 /CNW Telbec/ - Akela Pharma, Inc. ("Akela"), (TSX: AKL), an industry leader in providing contract drug formulation...
AUSTIN, TX, July 17, 2012 /PRNewswire/ - Akela Pharma, Inc. (TSX: AKL) today announced that Mr. Robert W. Rieder is stepping down as Chairman of the...
AUSTIN, TX, March 31, 2012 /PRNewswire/ - Akela Pharma, Inc. ("Akela"), (TSX: AKL), an industry leader in providing pharmaceutical contract dosage...
AUSTIN, TX, March 26, 2012 /PRNewswire/ - PharmaForm announced today that Corcept Therapeutics Inc. has chosen PharmaForm as their primary commercial ...
AUSTIN, TX, Nov. 15, 2011 /PRNewswire/ - Akela Pharma, Inc. ("Akela"), (TSX: AKL) and PharmaForm, a leading specialty contract service provider in...
AUSTIN, TX, Aug. 15, 2011 /PRNewswire/ - Akela Pharma, Inc. ("Akela"), (TSX: AKL) and PharmaForm, a leading specialty contract service provider in...
AUSTIN, TX, Jan. 18 /PRNewswire-FirstCall/ - PharmaForm, a leader in pharmaceutical formulation and clinical manufacturing, today announced several...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.